Cargando…

Adding ivabradine to beta-blockers in chronic heart failure: Do not rest without lowering the resting heart rate sufficiently

Detalles Bibliográficos
Autores principales:	Oomman, Abraham, Bansal, Manish
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993932/ https://www.ncbi.nlm.nih.gov/pubmed/29716694 http://dx.doi.org/10.1016/j.ihj.2018.03.009

Ejemplares similares

Resting heart rate in ambulatory heart failure with reduced ejection fraction treated with beta‐blockers
por: Varian, Kenneth D., et al.
Publicado: (2020)

Implication of Ivabradine in Up-titrating Beta-blocker in a Patient with Advanced Heart Failure
por: Hori, Masakazu, et al.
Publicado: (2020)

The Usefulness of Prioritization of Ivabradine Before Beta-Blockers in a Heart Failure Patient Suffering From Intra-hemodialysis Hypotension
por: Yamaguchi, Satoshi, et al.
Publicado: (2023)

Ivabradine tolerability in heart failure
por: Birkhoelzer, Sarah, et al.
Publicado: (2018)

In-hospital Heart Rate Reduction With Beta Blockers and Ivabradine Early After Recovery in Patients With Acute Decompensated Heart Failure Reduces Short-Term Mortality and Rehospitalization
por: Faragli, Alessandro, et al.
Publicado: (2021)

Ivabradine, the pure heart rate-lowering drug, shown to reduce morbidity and mortality in heart failure
Publicado: (2010)

Efficacy of Ivabradine in Combination with Beta-Blockers Versus Uptitration of Beta-Blockers in Patients with Stable Angina (CONTROL-2 Study)
por: Glezer, Maria, et al.
Publicado: (2018)

Advances in the management of heart failure: the role of ivabradine
por: Müller-Werdan, Ursula, et al.
Publicado: (2016)

Rest in Heart Disease
Publicado: (1902)

The effect of the heart rate lowering drug Ivabradine on hemodynamics in atherosclerotic mice
por: Xing, R., et al.
Publicado: (2018)

Effectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice
por: Perings, Stefan, et al.
Publicado: (2016)

The effect of beta-blockers in acute heart failure according to heart rate
por: Kim, Hyun-Jin, et al.
Publicado: (2021)

Budget Impact of Adding Ivabradine to Standard of Care in Patients with Chronic Systolic Heart Failure in the United States
por: Borer, Jeffrey S., et al.
Publicado: (2016)

Successful treatment with ivabradine in a β‐blocker‐refractory patient with acute decompensated heart failure with reduced ejection fraction
por: Inoue, Tomoko, et al.
Publicado: (2023)

Impact of Ivabradine on Inflammatory Markers in Chronic Heart Failure
por: Rohm, Ilonka, et al.
Publicado: (2016)

Cost‐Effectiveness of Ivabradine for Heart Failure in the United States
por: Kansal, Anuraag R., et al.
Publicado: (2016)

Ivabradine in Congestive Heart Failure: Patient Selection and Perspectives
por: Sattar, Yasar, et al.
Publicado: (2019)

Beta-Blockers and Oxidative Stress in Patients with Heart Failure
por: Nakamura, Kazufumi, et al.
Publicado: (2011)

New advances in beta-blocker therapy in heart failure
por: Barrese, Vincenzo, et al.
Publicado: (2013)

Lower In‐Hospital Mortality With Beta‐Blocker Use at Admission in Patients With Acute Decompensated Heart Failure
por: Tamaki, Yodo, et al.
Publicado: (2021)

Lower heart rates and beta-blockers are associated with new-onset atrial fibrillation
por: Habel, Nicole, et al.
Publicado: (2023)

Ivabradine in Combination with Beta-Blockers in Patients with Chronic Stable Angina After Percutaneous Coronary Intervention
por: Werdan, Karl, et al.
Publicado: (2015)

Adjuvant Use of Ivabradine in Acute Heart Failure due to Myocarditis
por: Franke, Jennifer, et al.
Publicado: (2011)

Economic evaluation of ivabradine in the treatment of chronic heart failure in Greece
por: Kourlaba, Georgia, et al.
Publicado: (2014)

Risk-benefit assessment of ivabradine in the treatment of chronic heart failure
por: Urbanek, Irmina, et al.
Publicado: (2014)

Role of Ivabradine in Patients with Heart Failure with Preserved Ejection Fraction
por: Nadeem, Muhammad, et al.
Publicado: (2020)

Association of ivabradin use with ventricular arrhythmias in heart failure patients
por: Pay, L, et al.
Publicado: (2023)

Ivabradine in patients with heart failure: a systematic literature review
por: Khan, Zeba M., et al.
Publicado: (2023)

Prognostic Value of Resting Pulmonary Function in Heart Failure
por: Olson, Thomas P., et al.
Publicado: (2013)

Can resting heart rate explain the heart rate and parasympathetic responses during rest, exercise, and recovery?
por: Garcia, Giliard Lago, et al.
Publicado: (2022)

Poor tolerance of beta-blockers by elderly patients with heart failure
por: Yanagisawa, Satoshi, et al.
Publicado: (2010)

Beta Blockers in Heart Failure: More Evidence for an Old Friend
por: Baek, Sang Hong
Publicado: (2018)

Treatment optimization of beta-blockers in chronic heart failure therapy
por: Niriayo, Yirga Legesse, et al.
Publicado: (2020)

Comparison of ivabradine plus β-blockers versus β-blocker therapy only
por: Aalbers, J
Publicado: (2010)

Does resting heart rate measured by the physician reflect the patient’s true resting heart rate? White-coat heart rate
por: Lequeux, Benoit, et al.
Publicado: (2018)

Ivabradine added to usual care in patients with heart failure: a systematic review with meta-analysis and trial sequential analysis
por: Maagaard, Mathias, et al.
Publicado: (2022)

Elevated resting heart rate in adolescent men and risk of heart failure and cardiomyopathy
por: Lindgren, Martin, et al.
Publicado: (2020)

Heart Rate Reduction by Ivabradine: Slowly but Surely?
por: Kojonazarov, Baktybek
Publicado: (2020)

Ivabradine Versus Beta-Blockers in Patients with Conduction Abnormalities or Left Ventricular Dysfunction Undergoing Cardiac Surgery
por: Iliuta, Luminita, et al.
Publicado: (2013)

Ivabradine, coronary artery disease, and heart failure: beyond rhythm control
por: Scicchitano, Pietro, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_k9akg4ue583fg1dsdkj1perrb8